secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0000950170-24-002728
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences preliminarily estimates $201.4M cash, 72.8M shares as of Dec 31, 2023
--------------------------------------------------------------------------------

- Preliminary cash, cash equivalents and marketable securities of approximately $201.4 million as of December 31, 2023.
- Common stock outstanding estimated at 72.8 million shares as of December 31, 2023.
- Estimates are unaudited and may change after completion of year-end closing and auditing procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024002728/0000950170-24-002728-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000095017024002728/kzr-20240108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-002728

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer